Psychedelic Bulletin: Big Pharma’s Foray Into Psychedelics; Psilocybin Trial Makes Headlines; Bill to Legalize Psilocybin in Washington State Filed

One of Otsuka Pharmaceutical’s U.S. arms has struck a deal with Mindset Pharma, constituting what Bloomberg describes as “a rare endorsement by big pharma of the new and mostly illegal field of drugs.” The collaboration was further explained in a press release, which explained that the McQuade Center for Strategic Research and Development (MSRD) has made an upfront cash payment of $5m to Mindset...

Source

Article Link: Psychedelic Bulletin: Big Pharma’s Foray Into Psychedelics; Psilocybin Trial Makes Headlines; Bill to Legalize Psilocybin in Washington State Filed - Psilocybin Alpha